Cutting edge:: Monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses

被引:43
|
作者
Dennehy, Kevin M.
Elias, Fernando
Zeder-Lutz, Gabrielle
Ding, Xin
Altschuh, Daniele
Luehder, Fred
Huenig, Thomas
机构
[1] Univ Wurzburg, Inst Virol & Immunbiol, D-97078 Wurzburg, Germany
[2] Univ Cape Town, Observ, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa
[3] Ecole Super Biotechnol Strasbourg, CNRS, UMR 7175, Illkirch Graffenstaden, France
[4] TeGenero Immunotherapeut, Wurzburg, Germany
[5] Inst Multiple Sklerose Forsch, Gottingen, Germany
来源
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷 / 10期
关键词
D O I
10.4049/jimmunol.176.10.5725
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD28 and CTLA-4 are the major costimulatory receptors on naive T cells. But it is not clear why CD28 is monovalent whereas CTLA-4 is bivalent for their shared ligands CD80186. We generated bivalent CD28 constructs by fusing the extracellular domains of CTLA-4 or CD80 with the intracellular domains of CD28. Bivalent or monovalent CD28 constructs were ligated with recombinant ligands with or without TCR coligation. Monovalent CD28 ligation did not induce responses unless the TCR was coligated. By contrast, bivalent CD28 ligation induced responses in the absence of TCR engagement. To extend these findings to primary cells, we used novel superagonistic and conventional CD28Abs. Superagonistic Ab D665, but not conventional Ab E18, predominantly ligates CD28 bivalently at low CD28/Ab ratios and induces A&independent - T cell proliferation. Monovalency of CD28 for its natural ligands is thus essential toprovide costimulation without inducing responses in the absence of TCR engagement.
引用
收藏
页码:5725 / 5729
页数:5
相关论文
共 50 条
  • [21] Memory CD8+ T cell responses require CD28 costimulation
    Borowski, Annie B.
    Boesteanu, Alina
    Dolfi, Douglas V.
    Mueller, Yvonne M.
    Carafides, Caterina
    Katsikis, Peter D.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S184 - S184
  • [22] Cutting edge:: Blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells
    Newell, KA
    He, G
    Guo, Z
    Kim, O
    Szot, GL
    Rulifson, I
    Zhou, P
    Hart, J
    Thistlethwaite, JR
    Bluestone, JA
    JOURNAL OF IMMUNOLOGY, 1999, 163 (05): : 2358 - 2362
  • [23] A novel costimulatory signaling in human T lymphocytes by a splice variant of CD28
    Hanawa, H
    Ma, Y
    Mikolajczak, SA
    Charles, ML
    Yoshida, T
    Yoshida, R
    Strathdee, CA
    Litchfield, DW
    Ochi, A
    BLOOD, 2002, 99 (06) : 2138 - 2145
  • [24] Novel Phosphorylation Sites in the CD28 Costimulatory Domain Shape CAR-T Cell Function
    Ramello, Maria C.
    Fang, Bin
    Koomen, John M.
    Haura, Eric B.
    Abate-Daga, Daniel
    MOLECULAR THERAPY, 2018, 26 (05) : 52 - 53
  • [25] Mutation of the CD28 costimulatory domain confers increased CAR T cell persistence and decreased exhaustion
    Boucher, Justin C.
    Li, Gongbo
    Shrestha, Bishwas
    Zhang, Yongliang
    Vishwasrao, Paresh
    Cabral, Maria L.
    Guan, Lawrence
    Davila, Marco L.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [26] CD28 T cell costimulatory receptor function is negatively regulated by N-linked carbohydrates
    Ma, BY
    Mikolajczak, SA
    Yoshida, T
    Yoshida, R
    Kelvin, DJ
    Ochi, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (01) : 60 - 67
  • [27] CD28 costimulatory signal induces protein arginine methylation in T cells
    Blanchet, F
    Cardona, A
    Letimier, FA
    Hershfield, MS
    Acuto, O
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (03): : 371 - 377
  • [28] Roquin Differentiates the Specialized Functions of Duplicated T Cell Costimulatory Receptor Genes Cd28 and Icos
    Linterman, Michelle A.
    Rigby, Robert J.
    Wong, Raphael
    Silva, Diego
    Withers, David
    Anderson, Graham
    Verma, Naresh K.
    Brink, Robert
    Hutloff, Andreas
    Goodnow, Chris C.
    Vinuesa, Carola G.
    IMMUNITY, 2009, 30 (02) : 228 - 241
  • [29] T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
    Hui, Enfu
    Cheung, Jeanne
    Zhu, Jing
    Su, Xiaolei
    Taylor, Marcus J.
    Wallweber, Heidi A.
    Sasmal, Dibyendu K.
    Huang, Jun
    Kim, Jeong M.
    Mellman, Ira
    Vale, Ronald D.
    SCIENCE, 2017, 355 (6332) : 1428 - +
  • [30] Suggestion or a unique CD28 costimulatory mechanism in human T cells.
    Matsubara, H
    Shearer, GM
    FASEB JOURNAL, 1996, 10 (06): : 2619 - 2619